Sandoz
Executive Summary
Former FDAer Marion Finkel, MD, appointed VP-drug registration and regulatory affairs at Sandoz Research Institute. She will report directly to institute president Robert Levy, MD. Finkel joins Sandoz from Berlex Labs, where she was executive director of R&D.